Preoperative Prediction of Axillary Lymph Node Metastasis in Patients with Breast Cancer Based on Radiomics of Gray-scale Ultrasonography
Overview
Affiliations
Background: To investigate the performance of a radiomics model based on gray-scale ultrasonography (US) for the preoperative non-invasive prediction of ipsilateral axillary lymph node (ALN) metastasis in patients with breast cancer (BC).
Methods: A total of 192 pathologically confirmed BC patients were included in this study. The training set was comprised of 132 patients from hospital 1 and the test set was comprised of 60 patients from hospital 2. All patients underwent US before percutaneous core biopsy and the results of ALN status reported by a radiologist with 12 years of experience were recorded. Radiomic features were extracted from the gray-scale US images. Max-relevance and min-redundancy (MRMR) and least absolute shrinkage and selection operator (LASSO) were used for data dimension reduction and feature selection. A radiomics model was constructed using LASSO and was validated using the leave group out cross-validation (LGOCV) method. The performance of the model was validated with receiver operating characteristic (ROC), calibration curve, and decision curve analysis.
Results: A total of 860 features were extracted from the gray-scale US images of each breast lesion, and 9 radiomic features were selected for model construction. The area under the curve (AUC), sensitivity, and specificity of the model for predicting ALN metastasis were 0.85, 78.9%, and 77.3% in the training set and 0.65, 68.0%, and 79.4% in the test set, respectively. The prediction performance of the model was significantly higher than that of the radiologist (AUC: 0.85 0.59, P<0.01) in the training set and was slightly higher than that of the radiologist (AUC: 0.65 0.63, P>0.05) in the test set.
Conclusions: The non-invasive radiomics model has the ability to predict ALN metastasis for patients with breast cancer and may outperform US-reported ALN status performed by the radiologist.
Liu J, Yan C, Liu C, Wang Y, Chen Q, Chen Y Front Oncol. 2024; 14:1403522.
PMID: 39055558 PMC: 11269194. DOI: 10.3389/fonc.2024.1403522.
Qin J, Qin X, Duan Y, Xie Y, Zhou Y, Zhang C Transl Cancer Res. 2024; 13(1):317-329.
PMID: 38410225 PMC: 10894355. DOI: 10.21037/tcr-23-1042.
Application and prospects of AI-based radiomics in ultrasound diagnosis.
Zhang H, Meng Z, Ru J, Meng Y, Wang K Vis Comput Ind Biomed Art. 2023; 6(1):20.
PMID: 37828411 PMC: 10570254. DOI: 10.1186/s42492-023-00147-2.
Guo Y, Wu J, Wang Y, Jin Y Diagnostics (Basel). 2022; 12(12).
PMID: 36553137 PMC: 9776855. DOI: 10.3390/diagnostics12123130.
Wu J, Ge L, Jin Y, Wang Y, Hu L, Xu D Front Oncol. 2022; 12:993466.
PMID: 36530981 PMC: 9749858. DOI: 10.3389/fonc.2022.993466.